Delivery Order SPE2DB20D1100-SPE2DB25FE0HA
- Not listed
- The Defense Logistics Agency awarded a $1,095.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ketamine 500 mg/5 mL vials. This firm fixed price contract, with an ultimate completion date of September 4, 2025, represents a non-set-aside competitive award for pharmaceutical delivery to support federal medical procurement needs. The product will be sourced and distributed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,005.60 for 500 mg/5 mL ketamine vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical product for federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $2,001.20 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ketamine 200 mg/20 ml vials. This firm fixed-price contract, classified as a non-set-aside award, is scheduled for completion by September 16, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.80 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ketamine 200 mg/20 mL vials. This non-set-aside, firm fixed-price contract is scheduled for completion by May 28, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive procurement action under the company's existing contract vehicle with DLA. This award falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $4,847.38 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 mL vials on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price, competitively awarded delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's demonstrated capability to compete in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ketamine 500mg/5mL in quantities of 10, with a ceiling value of $1,076.58 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,817,954 units of Ketamine 200 mg/20 ml vials with a completion date of March 1, 2024 and a potential value of $1,501.50. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 31, 2025, which serves as the...
- This federal contract award of $1,582.95 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Ketamine 500 mg/5 ml vials with a completion date of June 14, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This is a federal contract award for the delivery of 500 mg/5 ml vials of the pharmaceutical drug Ketamine. The contract, valued at $1,095.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a large Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0HADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ketamine 500 mg/5 mL vials with a ceiling value of $1,187.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively rendered. The contract is expected to reach ultimate completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's established track record of competitively awarded contracts with DLA, combined with its expansive pharmaceutical portfolio spanning specialty medications, brand-name and generic drugs, and medical supplies, positions it as a key provider within the Defense Health Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |